COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1028 |
Resumo: | This systematic review aims to compare the drugs used for the treatment of COVID-19 in diagnosed and hospitalized patients. The search in the databases generated 97 references, which after the selection and eligibility process, 4 systematic reviews (SR) were selected and used in this narrative synthesis where their data were extracted. The AMSTAR 2 tool was used in the evaluation of methodological quality. The options were grouped according to the adopted interventions: Tocilizumab, Vitamin D, and Atorvastatin. It is concluded that the study has limitations in its methodology, and the results should be analyzed with caution. The presented options need to describe the standard treatment used. Tocilizumab appears to be the best choice in concurrent use with standard treatment. |
id |
GOE-1_c3a12822aa255d01d2b640863bee929b |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1028 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19COMPARAÇÃO DE TRATAMENTOS MEDICAMENTOSOS EM PACIENTES INTERNADOS COM COVID19Tratamento Farmacológico da COVID-19COVID19Revisão sistemáticaCOVID-19 Drug TreatmentCOVID19Systematic ReviewThis systematic review aims to compare the drugs used for the treatment of COVID-19 in diagnosed and hospitalized patients. The search in the databases generated 97 references, which after the selection and eligibility process, 4 systematic reviews (SR) were selected and used in this narrative synthesis where their data were extracted. The AMSTAR 2 tool was used in the evaluation of methodological quality. The options were grouped according to the adopted interventions: Tocilizumab, Vitamin D, and Atorvastatin. It is concluded that the study has limitations in its methodology, and the results should be analyzed with caution. The presented options need to describe the standard treatment used. Tocilizumab appears to be the best choice in concurrent use with standard treatment.Esta revisão sistemática tem por objetivo comparar os medicamentos utilizados para tratamento da covid19 em pacientes diagnosticados com a doença e internados. A busca nas bases e dados gerou 97 referências, que após o processo de seleção e elegibilidade, foram selecionadas 4 revisões sistemáticas (RS) utilizadas nesta síntese narrativa onde seus dados foram extraídos. A ferramenta AMSTAR 2 foi utilizada na avaliação da qualidade metodológica. As opções foram agrupadas de acordo com as intervenções adotadas: Tociluzumabe, vitamina D e Atorvastatina. Conclui-se que o estudo possui limitações em sua metodologia, devendo os resultados serem analisados com prudência. As opções apresentadas necessitam descrever o tratamento padrão utilizado. O tociluzumabe se mostra a melhor escolha em uso concomitante com o tratamento padrão.Specialized Dentistry Group2024-01-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/102810.36557/2674-8169.2024v6n1p212-227Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 1 (2024): BJIHS QUALIS B3; 212-227Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 1 (2024): BJIHS QUALIS B3; 212-227Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 1 (2024): BJIHS QUALIS B3; 212-2272674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1028/1367Copyright (c) 2024 Edgard Lindesay Neto, Alexandre Maslinkiewicz, Nicole Pischelhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLindesay Neto, EdgardMaslinkiewicz, AlexandrePischel, Nicole2024-01-05T19:28:44Zoai:ojs.bjihs.emnuvens.com.br:article/1028Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2024-01-05T19:28:44Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19 COMPARAÇÃO DE TRATAMENTOS MEDICAMENTOSOS EM PACIENTES INTERNADOS COM COVID19 |
title |
COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19 |
spellingShingle |
COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19 Lindesay Neto, Edgard Tratamento Farmacológico da COVID-19 COVID19 Revisão sistemática COVID-19 Drug Treatment COVID19 Systematic Review |
title_short |
COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19 |
title_full |
COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19 |
title_fullStr |
COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19 |
title_full_unstemmed |
COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19 |
title_sort |
COMPARISON OF DRUG TREATMENTS IN HOSPITALIZED PATIENTS WITH COVID-19 |
author |
Lindesay Neto, Edgard |
author_facet |
Lindesay Neto, Edgard Maslinkiewicz, Alexandre Pischel, Nicole |
author_role |
author |
author2 |
Maslinkiewicz, Alexandre Pischel, Nicole |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Lindesay Neto, Edgard Maslinkiewicz, Alexandre Pischel, Nicole |
dc.subject.por.fl_str_mv |
Tratamento Farmacológico da COVID-19 COVID19 Revisão sistemática COVID-19 Drug Treatment COVID19 Systematic Review |
topic |
Tratamento Farmacológico da COVID-19 COVID19 Revisão sistemática COVID-19 Drug Treatment COVID19 Systematic Review |
description |
This systematic review aims to compare the drugs used for the treatment of COVID-19 in diagnosed and hospitalized patients. The search in the databases generated 97 references, which after the selection and eligibility process, 4 systematic reviews (SR) were selected and used in this narrative synthesis where their data were extracted. The AMSTAR 2 tool was used in the evaluation of methodological quality. The options were grouped according to the adopted interventions: Tocilizumab, Vitamin D, and Atorvastatin. It is concluded that the study has limitations in its methodology, and the results should be analyzed with caution. The presented options need to describe the standard treatment used. Tocilizumab appears to be the best choice in concurrent use with standard treatment. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-01-05 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1028 10.36557/2674-8169.2024v6n1p212-227 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1028 |
identifier_str_mv |
10.36557/2674-8169.2024v6n1p212-227 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1028/1367 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2024 Edgard Lindesay Neto, Alexandre Maslinkiewicz, Nicole Pischel https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2024 Edgard Lindesay Neto, Alexandre Maslinkiewicz, Nicole Pischel https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 1 (2024): BJIHS QUALIS B3; 212-227 Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 1 (2024): BJIHS QUALIS B3; 212-227 Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 1 (2024): BJIHS QUALIS B3; 212-227 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798442107830272 |